Statistics
Publications
3
Citations
53
H-Index
3
Active since
2020
Adenike Amadi is an author at Bristol-Myers Squibb (United Kingdom) specializing in immunotherapy, checkpoint inhibitor therapy, and immunotherapy for skin cancer.
Publications per year
2020–2022
3
3
1–3 of 3